Literature DB >> 21597369

Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets?

Brent M Egan1, Marilyn A Laken.   

Abstract

PURPOSE OF REVIEW: This review assesses whether controlling hypertension in 50% of all patients is the best we can do. RECENT
FINDINGS: NHANES 2007-2008 data show that blood pressure was controlled to less than 140/less than 90 mmHg in 50% of all hypertensive patients, an increase from 27% in 1988-1994. The 50% control rate reflects the product of 72.5% of all patients treated and 69% of all treated patients controlled. However, there are opportunities for improvement, as 27.5% of all hypertensives, or 55% of uncontrolled patients, were untreated in 2007-2008. These individuals are disproportionately younger, men, and Hispanic. Moreover, 31% of all treated hypertensives, or 45% of uncontrolled patients, have blood pressure of at least 140/at least 90 mmHg. They are disproportionately older, women, and black.
SUMMARY: Initiatives to raise hypertension treatment from 72.5% in 2007-2008 to 87.5% in the future are conceivable by targeting unaware and untreated patient groups and engaging them in ongoing healthcare. This could improve hypertension control by an absolute 10% of all patients. Reducing therapeutic inertia and increasing therapeutic efficiency could raise the proportion of patients on treatment who are controlled from 69 to 80% and could increase hypertension control by 8%. Combining these approaches could raise hypertension control to 70% of all hypertensive adults in the USA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21597369     DOI: 10.1097/HCO.0b013e3283474c20

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  6 in total

1.  Trends in blood pressure and hypertension detection, treatment, and control 1980 to 2009: the Minnesota Heart Survey.

Authors:  Russell V Luepker; Lyn M Steffen; David R Jacobs; Xia Zhou; Henry Blackburn
Journal:  Circulation       Date:  2012-09-07       Impact factor: 29.690

2.  Hypertension Awareness, Treatment, and Control in US Adults: Trends in the Hypertension Control Cascade by Population Subgroup (National Health and Nutrition Examination Survey, 1999-2016).

Authors:  Kathryn Foti; Dan Wang; Lawrence J Appel; Elizabeth Selvin
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

3.  Initial monotherapy and combination therapy and hypertension control the first year.

Authors:  Brent M Egan; Dipankar Bandyopadhyay; Stephanie R Shaftman; C Shaun Wagner; Yumin Zhao; Kristina S Yu-Isenberg
Journal:  Hypertension       Date:  2012-05-07       Impact factor: 10.190

4.  Evaluating factors associated with uncontrolled hypertension: Isfahan cohort study, Iran.

Authors:  Alireza Khosravi; Behrouz Pourheidar; Hamidreza Roohafza; Masoumeh Moezzi; Mehdi Mousavi; Alireza Hajiannejad; Peyman Bidram; Mojgan Gharipour; Shahin Shirani; Jafar Golshahi; Mansoureh Boshtam; Nizal Sarrafzadegan
Journal:  ARYA Atheroscler       Date:  2014-11

Review 5.  Pathophysiologically based antihypertensive pharmacotherapeutics rationality, efficacy and safety in Sub Saharan African Nations - A review.

Authors:  A A L Ajayi; O E Ajayi
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2021-10-28

6.  Treatment of hypertension among African Americans: the Jackson Heart Study.

Authors:  Jane Harman; Evelyn R Walker; Vicki Charbonneau; Ermeg L Akylbekova; Cheryl Nelson; Sharon B Wyatt
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-01       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.